Madrigal Pharmaceuticals (MDGL) SEC Filings & 10K Form

Madrigal Pharmaceuticals logo
$331.79 -5.77 (-1.71%)
Closing price 04:00 PM Eastern
Extended Trading
$332.35 +0.56 (+0.17%)
As of 04:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Madrigal Pharmaceuticals SEC Filings

DateFilerForm TypeView
01/27/2025
4:12 PM
Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
4:18 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
4:07 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
4:03 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
5:00 PM
Madrigal Pharmaceuticals (Subject)
Sibold William John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
5:00 PM
Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
5:00 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
5:00 PM
Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:05 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:08 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:10 PM
Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
4:30 PM
Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
4:30 PM
Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
4:30 PM
Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:50 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
3:46 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:16 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:10 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:30 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:30 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:18 PM
Madrigal Pharmaceuticals (Subject)
PAULSON & CO. INC. (Filed by)
Form SC 13G/A
11/14/2024
5:30 AM
Madrigal Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
11/08/2024
4:07 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:01 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:47 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
3:32 PM
Madrigal Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/31/2024
8:02 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
6:05 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
7:36 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
8:51 PM
Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
8:29 PM
Madrigal Pharmaceuticals (Subject)
Sibold William John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:16 PM
Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
6:52 PM
Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2024
7:58 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
6:06 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
8:46 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
8:41 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
8:42 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
8:42 PM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
8:45 PM
BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:03 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
The FED is losing the war on inflation (Ad)

It's no longer just a “guesstimate” – Inflation is indeed getting worse. And although we want to believe the Fed has a good grip on it, they don't. Right now, the suits over there are caught between a rock and a hard place. Either they watch as inflation grows, or they tear it down and send us into a full-blown recession. The kicker here is that neither of these are good for you. Whichever pill we end up with, prices will still climb higher as the value of the dollar sinks lower. The only real way out for the regular person is to increase your earning power. By increasing your income to match prices as they flare up… You’ll stay ahead of the impending doom we're running face-first into. And if you're looking for a strategy to help increase your income in 2025… I've got just the thing for you! You see, last year, I was able to grow a $10k model account to a little over $63k with 100 trade alerts But I changed my trading rules and more than doubled my results on those 100 published trades. I'm now calling them Warped Options…

You can go here to give yourself a head start.
06/27/2024
3:28 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
8:39 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
8:44 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:17 PM
Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
3:37 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
8:45 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:53 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
4:03 PM
Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
4:39 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2024
5:48 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
8:36 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
8:53 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:06 PM
Madrigal Pharmaceuticals (Filer)
Form S-3ASR
05/07/2024
8:00 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
6:06 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:49 PM
Madrigal Pharmaceuticals (Filer)
Form DEF 14A
04/10/2024
7:50 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
7:53 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
7:50 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
7:50 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:41 PM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:44 PM
BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:47 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
3:22 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:21 PM
BAKER BROS. ADVISORS LP (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:28 PM
BAKER BROS. ADVISORS LP (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
03/21/2024
3:30 PM
Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2024
3:11 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:10 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:01 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
5:32 AM
Madrigal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
1:50 PM
ARMISTICE CAPITAL, LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
8:21 AM
Avoro Capital Advisors LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
4:55 PM
JANUS HENDERSON GROUP PLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MDGL) was last updated on 2/11/2025 by MarketBeat.com Staff
From Our Partners